SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001564590-21-005799
Filing Date
2021-02-12
Accepted
2021-02-12 16:30:14
Documents
8

Document Format Files

Seq Description Document Type Size
1 8-K SHAREHOLDER LITIGATION snss-8k_20210212.htm 425 234670
2 GRAPHIC gaeigttl5qm4000006.jpg GRAPHIC 4185
3 GRAPHIC gaeigttl5qm4000007.jpg GRAPHIC 4185
4 GRAPHIC gaeigttl5qm4000005.jpg GRAPHIC 1533
5 GRAPHIC gaeigttl5qm4000003.jpg GRAPHIC 1533
6 GRAPHIC gaeigttl5qm4000002.jpg GRAPHIC 1533
7 GRAPHIC gaeigttl5qm4000004.jpg GRAPHIC 1533
8 GRAPHIC gaeigttl5qm4000001.jpg GRAPHIC 1533
  Complete submission text file 0001564590-21-005799.txt   259666
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filed by) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-51531 | Film No.: 21628111
SIC: 2834 Pharmaceutical Preparations